Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Mersana Therapeutics, Inc. Income Statement Banner

Mersana Therapeutics, Inc. Income Statement

MRSN Stock Analysis

Page title

Section title

Breakdown
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
10.359M25.171M17.545M10.594M42.123M828.000K43.000K26.581M36.855M
Cost of Revenue
21.353M32.008M928.000K59.915M55.040M67.036M132.013M927.000K1.517M
Gross Profit
-10.994m-6.837m16.617M-49.321m-12.917m-66.208m-131.970m25.654M35.338M
Operating Expense
26.700M38.992M57.162M76.249M72.323M88.938M168.901M230.348M206.295M
Operating Income
-16.341m-13.821m-39.617m-65.655m-29.219m-87.686m-169.713m-204.694m-170.957m
Other Income Expense
-89.000k0.0000.0001.398M0.0000.000-1.202m-445.000k8.713M
Total Other Income Expense
-89.000k121.000K910.000K1.398M1.011M-359.000k-347.000k482.000K-713.000k
Pretax Income
-16.428m-13.700m-38.707m-64.257m-28.208m-88.045m-170.060m-204.212m-171.670m
Tax Provision
-2.000k0.0000.0001.398M-1.011m359.000K-855.000k3.328M1.349M
Net Income
-16.428m-13.700m-38.707m-64.257m-27.197m-88.404m-169.205m-207.540m-171.670m
Basic EPS
-0.940-0.780-3.220-2.790-0.630-1.440-2.400-2.220-1.480
Diluted EPS
-0.940-0.780-3.220-2.790-0.630-1.440-2.400-2.220-1.480
Basic Average Shares
17.493M17.493M12.023M23.032M43.397M61.485M70.581M93.654M116.113M
Diluted Average Shares
17.493M17.493M12.023M23.032M43.492M61.485M70.581M93.654M116.113M
Total Expenses
26.700M38.992M57.162M76.249M72.323M88.938M168.901M230.348M207.812M
Interest Income
2.000K121.000K910.000K1.398M2.226M424.000K65.000K2.883M12.073M
Interest Expense
0.0000.0000.0000.000234.000K359.000K1.267M3.328M4.073M
EBITDA
-16.044m-13.166m-38.689m-65.655m-27.974m-86.676m-168.858m-203.767m-169.440m
Depreciation & Amortization
297.000K655.000K928.000K1.257M1.245M1.010M855.000K927.000K1.517M